Cosmos Health Inc
COSM0.487USD
-0.020-3.96%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
15.52MMarket Cap
LossP/E TTM
More Details of Cosmos Health Inc Company
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Cosmos Health Inc Info
Ticker SymbolCOSM
Company nameCosmos Health Inc
IPO dateMay 19, 2010
CEOSiokas (Grigorios)
Number of employees149
Security typeOrdinary Share
Fiscal year-endMay 19
Address5 Agiou Georgiou, Pilea
CityTHESSALONIKI
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryGreece
Postal code554 38
Phone303125363102
Websitehttps://www.cosmosholdingsinc.com/
Ticker SymbolCOSM
IPO dateMay 19, 2010
CEOSiokas (Grigorios)
Company Executives of Cosmos Health Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
6.46M
+4.89%
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
15.00K
--
Mr. Nikos Bardakis
Mr. Nikos Bardakis
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Theodoros C. Karkantzos
Mr. Theodoros C. Karkantzos
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
6.46M
+4.89%
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
15.00K
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Greece
921.13K
89.16%
United Arab Emirates (
130.79K
12.66%
SKOPJE North Macedonia
16.22K
1.57%
Croatia (Country)
10.68K
1.03%
Bulgaria
-49.00
0.00%
Other
-45.60K
-4.41%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Siokas (Grigorios)
18.98%
Bovopoulos (Andreas D)
4.16%
Terzis (Georgios)
2.08%
BlackRock Institutional Trust Company, N.A.
0.77%
The Vanguard Group, Inc.
0.68%
Other
73.33%
Shareholders
Shareholders
Proportion
Siokas (Grigorios)
18.98%
Bovopoulos (Andreas D)
4.16%
Terzis (Georgios)
2.08%
BlackRock Institutional Trust Company, N.A.
0.77%
The Vanguard Group, Inc.
0.68%
Other
73.33%
Shareholder Types
Shareholders
Proportion
Individual Investor
25.71%
Investment Advisor
1.55%
Hedge Fund
0.91%
Investment Advisor/Hedge Fund
0.70%
Venture Capital
0.19%
Research Firm
0.12%
Bank and Trust
0.02%
Other
70.80%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
39
1.21M
8.69%
--
2025Q3
40
1.21M
10.09%
+200.56K
2025Q2
40
1.01M
10.29%
-1.71M
2025Q1
38
2.72M
7.86%
+891.30K
2024Q4
38
1.62M
11.55%
-779.82K
2024Q3
39
2.40M
4.16%
+1.81M
2024Q2
40
591.35K
13.72%
-13.70K
2024Q1
40
605.05K
14.49%
-1.85M
2023Q4
39
1.97M
8.60%
+1.22M
2023Q3
36
746.56K
8.56%
-123.02K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Siokas (Grigorios)
6.16M
20.38%
--
--
Aug 01, 2025
Bovopoulos (Andreas D)
1.45M
4.81%
-427.73K
-22.74%
Aug 13, 2025
Terzis (Georgios)
727.26K
2.41%
--
--
Aug 01, 2025
BlackRock Institutional Trust Company, N.A.
267.80K
0.89%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
134.83K
0.45%
--
--
Jun 30, 2025
Citadel Advisors LLC
96.73K
0.32%
+96.73K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
191.56K
0.63%
-2.56K
-1.32%
Jun 30, 2025
XTX Markets LLC
36.70K
0.12%
+36.70K
--
Jun 30, 2025
Bardakis (Nikolaos)
45.00K
0.15%
--
--
Aug 01, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Date
Type
Ratio
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
FAQs
Who are the top five shareholders of Cosmos Health Inc?
The top five shareholders of Cosmos Health Inc are:
Siokas (Grigorios) holds 6.16M shares, accounting for 20.38% of the total shares.
Bovopoulos (Andreas D) holds 1.45M shares, accounting for 4.81% of the total shares.
Terzis (Georgios) holds 727.26K shares, accounting for 2.41% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 267.80K shares, accounting for 0.89% of the total shares.
The Vanguard Group, Inc. holds 134.83K shares, accounting for 0.45% of the total shares.
Siokas (Grigorios) holds 6.16M shares, accounting for 20.38% of the total shares.
Bovopoulos (Andreas D) holds 1.45M shares, accounting for 4.81% of the total shares.
Terzis (Georgios) holds 727.26K shares, accounting for 2.41% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 267.80K shares, accounting for 0.89% of the total shares.
The Vanguard Group, Inc. holds 134.83K shares, accounting for 0.45% of the total shares.
What are the top three shareholder types of Cosmos Health Inc?
The top three shareholder types of Cosmos Health Inc are:
Siokas (Grigorios)
Bovopoulos (Andreas D)
Terzis (Georgios)
Siokas (Grigorios)
Bovopoulos (Andreas D)
Terzis (Georgios)
How many institutions hold shares of Cosmos Health Inc (COSM)?
As of 2025Q4, 39 institutions hold shares of Cosmos Health Inc, with a combined market value of approximately 1.21M, accounting for 8.69% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -1.40%.
What is the biggest source of revenue for Cosmos Health Inc?
In FY2025Q2, the -- business generated the highest revenue for Cosmos Health Inc, amounting to -- and accounting for --% of total revenue.
